P03367 (POL_HV1BR) Human immunodeficiency virus type 1 group M subtype B (isolate BRU/LAI)(HIV-1)

Gag-Pol polyprotein UniProtKBInterProInteractive Modelling

1447 aa; Sequence (Fasta)

Available Structures

170 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
HIV-1 protease mutant I47V complexed with reaction intermediate
4flg
 Heteromer
501-1121
1×GLU; 1×ILE; 1×NA; 4×CL; 2×GOL;
Assess
STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN A COMPLEX WITH THE NONNUCLEOSIDE INHIBITOR ALPHA-APA R …
1hni
 Heteromer
P03366; 		600-1026
1×AAA;
Assess
Crystal Structure of E138K Mutant HIV-1 Reverse Transcriptase in Complex with Nevirapine
2hny
 Heteromer
P04585; 		606-1027
3×PO4; 1×MG; 1×NVP;
Assess
Crystal Structure of K101E Mutant HIV-1 Reverse Transcriptase in Complex with Nevirapine
2hnd
 Heteromer
P04585; 		606-1027
3×PO4; 1×MG; 1×NVP;
Assess
HIV-1 protease complexed with gem-diol-amine tetrahedral intermediate
4fl8
 Heteromer
501-599
5×CL; 2×GOL;
Assess
Crystal Structure of HIV-1 Protease (Q7K, I50V) in Complex with Tipranavir
2o4l
 Heteromer
Q1G1C3; 		501-599
2×CL; 1×TPV; 2×GOL;
Assess
Crystal Structure of HIV-1 Protease (Q7K) in Complex with Lopinavir
2o4s
 Heteromer
Q5RZ08; 		501-599
4×CL; 1×AB1; 2×GOL;
Assess
Crystal Structure of HIV-1 Protease (Q7K) in Complex with Atazanavir
2o4k
 Heteromer
Q903J0; 		501-599
1×CL; 1×DR7;
Assess
Crystal structure of the complex of mutant HIV-1 protease (A71V, V82T, I84V) with a hydroxyethylami…
1zpk
 Heteromer
Q7ZCL6; 		501-599
1×0ZS; 1×CL; 1×NA;
Assess
Crystal structure of HIV-1 protease complexed with a product of autoproteolysis
1sp5
 Heteromer
501-599
3×CL; 3×BME; 1×DMS;
Assess
Crystal structure of a complex of mutant hiv-1 protease (A71V, V82T, I84V) with a hydroxyethylamine…
1zbg
 Heteromer
Q7ZCL6; 		501-599
3×CL; 1×0ZS; 1×NA;
Assess
Crystal Structure of HIV-1 Protease (TRM Mutant) in Complex with Tipranavir
2o4n
 Heteromer
Q90SN9; 		501-599
1×TPV; 1×GOL;
Assess
Crystal structure of the complex of mutant HIV-1 protease (l63P, A71V, V82T, I84V) with a hydroxyet…
1z8c
 Heteromer
Q9JAU9; 		501-599
1×0ZS; 1×SO4;
Assess
Crystal structure of a complex of mutant HIV-1 protease (A71V, V82T, I84V) with a hydroxyethylamine…
1zlf
 Heteromer
Q7ZCL6; 		501-599
1×0ZR;
Assess
Substrate CA/p2 in Complex with a Human Immunodeficiency Virus Type 1 Protease Variant
4faf
 Heteromer
Q000H7; 		361-367
Assess
Core Catalytic Domain of HIV Integrase in complex with virtual screening hit
6vlm
homo-2-mer1216-1369
3×R2D;
Assess
Structure of HIV-1 Protease in Complex with Inhibitor KNI-1657
5yok
homo-2-mer501-599
1×8Z0; 2×GOL;
Assess
Crystal Structure of HIV-1 Protease Complexed with KNI-1689
3a2o
homo-2-mer501-599
1×GOL; 1×KNJ;
Assess
Structure of HIV-1 Protease in Complex with Potent Inhibitor KNI-272 Determined by High Resolution …
3fx5
homo-2-mer501-599
3×GOL; 1×KNI;
Assess
Wild Type HIV-1 Protease with potent Antiviral inhibitor GRL-0255A
3djk
homo-2-mer501-599
2×NA; 3×CL; 1×G55;
Assess
1.03 A structure of HIV-1 protease: inhibitor binding inside and outside the active site
1nh0
homo-2-mer501-599
2×SO4; 2×BME;
Assess
HIV-1 Protease Saquinavir:Ritonavir 1:50 complex structure
3ndx
homo-2-mer501-599
1×RIT; 4×DMS; 2×GOL; 1×CL; 2×SO4;
Assess
Cystal structure of HIV-1 Active Site Mutant D25N and p2-NC analog inhibitor
3bva
homo-2-mer501-599
3×GOL; 1×2NC;
Assess
Crystal Structure of HIV-1 protease mutants I54M complexed with inhibitor GRL-0519
4he9
homo-2-mer501-599
1×G52; 1×NA; 5×CL;
Assess
Wild Type HIV-1 Protease with potent Antiviral inhibitor GRL-0105A
3dk1
homo-2-mer501-599
1×NA; 3×CL; 1×G05;
Assess
HIV-1 Protease Mutant V82A with potent Antiviral inhibitor GRL-98065
2qd7
homo-2-mer501-599
2×PO4; 2×DMS; 2×GOL; 1×065;
Assess
HIV-1 Protease - Epoxydic Inhibitor Complex (pH 9 - Orthorombic Crystal form P212121)
3toh
homo-2-mer501-599
1×079; 3×DMS;
Assess
HIV-1 wild type protease with GRL-03419A, with N-(2,5-dimethylphenyl)-4-(pyridin-3-yl)pyrimidin-2-a…
8fuj
homo-2-mer501-599
1×NA; 4×CL; 2×FMT; 1×Y9N; 1×GOL;
Assess
HIV-1 wild type protease with GRL-05816A, with C-4 substituted cyclohexane-fused bis-tetrahydrofura…
7to5
homo-2-mer501-599
1×NA; 3×CL; 1×FMT; 1×G8R; 1×GOL;
Assess
HIV-1 Protease Saquinavir:Ritonavir 1:15 complex structure
3ndw
homo-2-mer501-599
1×RIT; 3×DMS; 2×SO4; 2×NA; 1×ACT;
Assess
Crystal structure of wild type HIV-1 protease with macrocyclic inhibitor GRL-0216A
3i6o
homo-2-mer501-599
2×NA; 19×IOD; 2×GOL; 1×GR6;
Assess
HIV-1 wild type protease with GRL-026-18A, a crown-like tetrahydropyranotetrahydrofuran with a brid…
6vce
homo-2-mer501-599
1×NA; 6×CL; 1×G6R; 2×GOL;
Assess
HIV-1 Protease mutant D30N with potent Antiviral inhibitor GRL-98065
2qci
homo-2-mer501-599
1×NA; 2×CL; 1×ACT; 1×065;
Assess
HIV-1 wild type protease with GRL-01717A, with C-4 substituted cyclohexane-fused bis-tetrahydrofura…
7to6
homo-2-mer501-599
1×NA; 3×CL; 1×G77; 1×ACT;
Assess
Crystal Structure of HIV-1 protease mutants I50V complexed with inhibitor GRL-0519
4hdp
homo-2-mer501-599
1×G52; 2×NA; 6×CL;
Assess
Crystal Structure of Wild-type HIV-1 Protease with Cyclopentyltetrahydro- furanyl Urethanes as P2-l…
4dfg
homo-2-mer501-599
2×NA; 4×CL; 1×0JV;
Assess
HIV-1 Protease - Epoxydic Inhibitor Complex (pH 9 - Monoclinic Crystal form P21)
3tog
homo-2-mer501-599
2×DMS; 1×079;
Assess
Crystal Structure of a highly resistant HIV-1 protease Clinical isolate PR10x with GRL-0519 (tris-t…
8dch
homo-2-mer501-599
1×G52; 2×CL; 1×GOL;
Assess
Crystal Structure of HIV-1 Protease Mutant I47V with novel P1'-Ligands GRL-02031
3vf5
homo-2-mer501-599
2×NA; 4×CL; 2×ACT; 1×031; 1×GOL;
Assess
Crystal structures of HIV protease V82A and L90M mutants reveal changes in indinavir binding site.
1sdu
homo-2-mer501-599
1×SO4; 1×ACT; 1×MK1;
Assess
HIV-1 Protease Saquinavir:Ritonavir 1:5 complex structure
3ndu
homo-2-mer501-599
1×ROC; 2×DMS; 3×ACT; 4×CL; 2×GOL; 3×NA;
Assess
HIV-1 wild type protease with GRL-02519A, with N-(2,5-dimethylphenyl)-4-(pyridin-3-yl)pyrimidin-2-a…
8fui
homo-2-mer501-599
1×Y9R; 2×NA; 4×CL; 1×ACT; 1×GOL; 2×FMT;
Assess
HIV-1 wild type protease with GRL-052-16A, a tricyclic cyclohexane fused tetrahydrofuranofuran (CHf…
6vod
homo-2-mer501-599
1×NA; 2×CL; 1×GOL; 1×T1R; 1×FMT;
Assess
HIV-1 Protease Mutant I50V with potent Antiviral inhibitor GRL-98065
2qd6
homo-2-mer501-599
1×NA; 2×CL; 2×ACT; 1×065;
Assess
Crystal structure of wild type HIV-1 protease with novel P1'-ligand GRL-02031
3h5b
homo-2-mer501-599
1×NA; 2×CL; 1×031; 1×GOL;
Assess
Crystal Structure of HIV-1 protease mutants V82A complexed with inhibitor GRL-0519
4hdf
homo-2-mer501-599
1×CL; 1×G52;
Assess
HIV-1 wild type protease with GRL-019-17A, a tricyclic cyclohexane fused tetrahydrofuranofuran (CHf…
6voe
homo-2-mer501-599
1×NA; 2×CL; 2×ACT; 1×T2R;
Assess
Cystal structure of HIV-1 Active Site Mutant D25N and inhibitor Darunavir
3bvb
homo-2-mer501-599
1×NA; 1×CL; 1×017; 1×GOL;
Assess
Crystal structure analysis of HIV-1 protease with a potent non-peptide inhibitor (UIC-94017)
2ien
homo-2-mer501-599
1×NA; 2×CL; 2×ACY; 1×017; 2×GOL;
Assess
High resolution structure of HIV-1 PR with TS-126
2a1e
homo-2-mer501-599
5×DMS; 1×NA; 1×CL; 2×ACT; 1×IPF; 1×GOL;
Assess
Crystal Structure of HIV-1 Protease Mutant L76V with novel P1'-Ligands GRL-02031
3vf7
homo-2-mer501-599
1×031; 2×NA; 3×CL; 5×GOL;
Assess
Crystal structures of HIV protease V82A and L90M mutants reveal changes in indinavir binding site.
1sdt
homo-2-mer501-599
2×CL; 1×MK1;
Assess
Crystal Structure of Multidrug Resistant HIV-1 Protease Clinical isolate PR20 with the potent antiv…
4j55
homo-2-mer501-599
2×031;
Assess
Crystal structure of inhibitor-free HIV-1 PRS17 revertant mutant PRS17 V48G
7n6t
homo-2-mer501-599
Assess
Structure of HIV1 protease and AKC4p_133a complex.
2bb9
homo-2-mer501-599
1×AKC;
Assess
HIV-1 Protease Mutant I84V with potent Antiviral inhibitor GRL-98065
2qd8
homo-2-mer501-599
1×NA; 2×CL; 2×ACT; 1×065;
Assess
Crystal Structure of Multidrug Resistant HIV-1 Protease Clinical Isolate PR20 in Complex with Darun…
3ucb
homo-2-mer501-599
2×017;
Assess
HIV-1 protease (mutant Q7K L33I L63I) in complex with a novel inhibitor
3qn8
homo-2-mer501-599
3×CL; 1×NI7;
Assess
HIV-1 protease (mutant Q7K L33I L63I) in complex with a novel inhibitor
3qih
homo-2-mer501-599
2×FG7; 3×CL; 1×NI7; 1×PGE;
Assess
Crystal structure of HIV-1 Protease multiple mutants PRS17 with Revertant mutation V48G bound to in…
7n6v
homo-2-mer501-599
1×478; 2×GOL;
Assess
HIV-1 protease mutant V32I complexed with reaction intermediate
4fm6
homo-2-mer501-599
1×NA; 6×CL; 1×GOL;
Assess
Crystal structures of HIV protease V82A and L90M mutants reveal changes in indinavir binding site.
1sdv
homo-2-mer501-599
2×CL; 1×MK1;
Assess
HIV-1 Protease in complex with a iodo decorated pyrrolidine-based inhibitor
2qnp
homo-2-mer501-599
3×CL; 1×QN2;
Assess
HIV-1 protease (mutant Q7K L33I L63I) in complex with a novel inhibitor
3qp0
homo-2-mer501-599
3×CL; 1×NI8;
Assess
HIV-1 Protease - Epoxydic Inhibitor Complex (pH 6 - Orthorombic Crystal form P212121)
3tof
homo-2-mer501-599
1×076; 2×ACT; 2×DMS;
Assess
HIV-1 protease (mutant Q7K L33I L63I) in complex with a three-armed pyrrolidine-based inhibitor
3qbf
homo-2-mer501-599
1×JHG; 3×GOL; 3×CL;
Assess
HIV-1 Protease Mutant L76V complexed with Saquinavir
3pwr
homo-2-mer501-599
1×ROC; 1×CL; 8×GOL;
Assess
Crystal structure of wild-type HIV-1 protease with C3-Substituted Hexahydrocyclopentafuranyl Uretha…
3st5
homo-2-mer501-599
2×CL; 1×G89;
Assess
Crystal Structure of Multidrug Resistant HIV-1 Protease Clinical Isolate PR20 in Complex with Saqui…
3ufn
homo-2-mer501-599
2×ROC; 2×CL;
Assess
Crystal Structure of HIV-1 protease mutants R8Q complexed with inhibitor GRL-0519
4heg
homo-2-mer501-599
1×G52;
Assess
HIV-1 Protease Mutant L76V with Darunavir
3pwm
homo-2-mer501-599
2×CL; 3×ACT; 1×NA; 1×017;
Assess
Crystal structure of HIV-1 Protease multiple mutants PRS17 bound to inhibitor Amprenavir
7n6x
homo-2-mer501-599
1×478;
Assess
HIV-1 protease in complex with a multiple decorated pyrrolidine-based inhibitor
2qnn
homo-2-mer501-599
2×GOL; 2×CL; 1×QN1;
Assess
Crystal Structure of HIV-1 protease mutants D30N complexed with inhibitor GRL-0519
4hdb
homo-2-mer501-599
1×G52; 1×NA; 2×CL;
Assess
HIV-1 protease in complex with a carbamoyl decorated pyrrolidine-based inhibitor
2pwr
homo-2-mer501-599
3×CL; 1×G4G; 1×GOL;
Assess
HIV-1 Protease in complex with pyrrolidinmethanamine
1xl2
homo-2-mer501-599
2×CL; 1×189; 1×GOL;
Assess
Drug Resistant HIV-1 Protease (L10F, M46I, I50V, F53L, L63P, G73S) in Complex with DRV
7mas
homo-2-mer501-599
1×017;
Assess
Crystal Structure of Multidrug Resistant HIV-1 Protease Clinical isolate PR20 with the potent antiv…
4j54
homo-2-mer501-599
2×G52; 22×IOD; 1×ACT;
Assess
HIV-1 Protease in complex with a pyrrolidine-based inhibitor
2pqz
homo-2-mer501-599
3×CL; 1×G0G;
Assess
Structural and kinetic analysis of drug resistant mutants of HIV-1 protease
1daz
homo-2-mer501-599
1×0Q4;
Assess
Crystal Structure of HIV-1 Protease Mutant N88D with novel P1'-Ligands GRL-02031
3vfb
homo-2-mer501-599
1×031; 2×CL; 3×GOL; 1×NA;
Assess
I50V HIV-1 protease in complex with an amino decorated pyrrolidine-based inhibitor
2r43
homo-2-mer501-599
3×CL; 1×GOL; 1×G3G;
Assess
HIV-1 protease (mutant Q7K L33I L63I) in complex with a three-armed pyrrolidine-based inhibitor
3qrs
homo-2-mer501-599
3×CL; 1×NK8;
Assess
Wild Type HIV-1 Protease with potent Antiviral inhibitor GRL-98065
2z4o
homo-2-mer501-599
1×NA; 2×CL; 1×ACT; 1×065;
Assess
HIV-1 Protease Mutant G86A with DARUNAVIR
3jvy
homo-2-mer501-599
1×NA; 2×CL; 1×017;
Assess
HIV-1 protease (mutant Q7K L33I L63I) in complex with a three-armed pyrrolidine-based inhibitor
3qpj
homo-2-mer501-599
3×CL; 1×N4I; 1×DTD;
Assess
HIV-1 protease (mutant Q7K L33I L63I) in complex with a three-armed pyrrolidine-based inhibitor
3qro
homo-2-mer501-599
1×NK9; 1×DTD; 3×CL; 1×GOL;
Assess
Crystal Structure of a highly resistant HIV-1 protease Clinical isolate PR10x (inhibitor-free)
8dci
homo-2-mer501-599
Assess
Crystal Structure of Multidrug Resistant HIV-1 Protease Clinical isolate PR20
3uf3
homo-2-mer501-599
2×Y1; 1×GOL;
Assess
HIV-1 protease in complex with a dimethylallyl decorated pyrrolidine based inhibitor (orthorombic s…
3ckt
homo-2-mer501-599
2×CL; 1×YDP;
Assess
HIV-1 protease in complex with a dimethylallyl decorated pyrrolidine based inhibitor (hexagonal spa…
2zga
homo-2-mer501-599
2×YDP;
Assess
HIV-1 Protease multiple mutant PRS5B with Darunavir
6p9a
homo-2-mer501-599
4×PO4; 1×017;
Assess
Crystal Structure of HIV-1 Protease (Q7K, L33I, L63I) in Complex with KNI-10006
3kdb
homo-2-mer501-599
1×GOL; 1×006;
Assess
Crystal structure of a metallacarborane inhibitor bound to HIV protease
3i8w
homo-2-mer501-599
2×CB5; 2×CL; 2×GOL;
Assess
HIV-1 PROTEASE IN COMPLEX WITH A DIFLUOROKETONE CONTAINING INHIBITOR A79285
1dif
homo-2-mer501-599
2×BME; 1×A85;
Assess
Drug Resistant HIV-1 Protease (L10F, M46I, I47V, I50V, F53L, L63P, I72V, G73S, V82I, I85V) in Compl…
7mar
homo-2-mer501-599
1×017;
Assess
Crystal Structure of HIV-1 Protease in Complex with KNI-10772
3nls
homo-2-mer501-599
1×GOL; 1×URE; 1×016; 1×DMS;
Assess
HIV-1 Protease in complex with amidhyroxysulfone
1xl5
homo-2-mer501-599
3×CL; 1×190;
Assess
HIV-1 protease (mutant Q7K L33I L63I) in complex with a three-armed pyrrolidine-based inhibitor
3qrm
homo-2-mer501-599
1×NK7; 3×CL; 1×DTD;
Assess
HIV-1 protease in complex with a three armed pyrrolidine derivative
3bhe
homo-2-mer501-599
1×BZN;
Assess
HIV-1 Protease multiple drug resistant mutant PRS5B with Amprenavir
6p9b
homo-2-mer501-599
1×478; 4×PO4;
Assess
HIV-1 protease in complex with a amino decorated pyrrolidine-based inhibitor
2pwc
homo-2-mer501-599
3×CL; 1×G3G; 1×GOL;
Assess
HIV-1 protease (mutant Q7K L33I L63I) in complex with a bicyclic pyrrolidine inhibitor
4gb2
homo-2-mer501-599
3×CL; 2×GOL; 1×0LQ;
Assess
HIV-1 Protease Mutant G86A with symmetric inhibitor DMP323
3jvw
homo-2-mer501-599
1×DMP;
Assess
HIV-1 Protease Mutant G86S with DARUNAVIR
3jw2
homo-2-mer501-599
1×017; 1×NA; 1×CL;
Assess
Crystal Structure of Multidrug Resistant HIV-1 Protease Clinical Isolate PR20 in Complex with Ampre…
4j5j
homo-2-mer501-599
3×CL; 2×478;
Assess
Crystal Structure of HIV-1 Protease (Q7K, L33I, L63I) in Complex with KNI-10265
3kdd
homo-2-mer501-599
1×JZQ; 2×GOL;
Assess
INFLUENCE OF STEREOCHEMISTRY ON ACTIVITY AND BINDING MODES FOR C2 SYMMETRY-BASED DIOL INHIBITORS OF…
1hvl
homo-2-mer501-599
1×A76;
Assess
HIV PR drug resistant patient's variant in complex with darunavir
3ggu
homo-2-mer501-599
1×017;
Assess
CRYSTAL STRUCTURE OF HIV-1 PROTEASE COMPLEXED WITH A HYDROXYETHYLAMINE PEPTIDOMIMETIC INHIBITOR
1iiq
homo-2-mer501-599
1×0ZR; 5×GOL;
Assess
HIV-1 PR mutant in complex with nelfinavir
2pyn
homo-2-mer501-599
1×1UN;
Assess
HIV-1 Protease (I84V) in Complex with UMass9
7ma9
homo-2-mer501-599
3×SO4; 1×K2E;
Assess
HIV-1 PR mutant in complex with nelfinavir
2pym
homo-2-mer501-599
1×1UN;
Assess
Comparing the Accumulation of Active Site and Non-active Site Mutations in the HIV-1 Protease
1sgu
homo-2-mer501-599
1×MK1;
Assess
HIV-1 Protease (I84V) in Complex with UMass8
7ma8
homo-2-mer501-599
2×SO4; 1×F53;
Assess
HIV-1 Protease (I84V) in Complex with UMass7
7ma7
homo-2-mer501-599
2×SO4; 1×K2D;
Assess
Crystal structure of a complex of mutant HIV-1 protease (A71V, V82T, I84V) with a hydroxyethylamine…
1zj7
homo-2-mer501-599
2×0ZT;
Assess
Drug Resistant HIV-1 Protease (L10F, V32I, L33F, K45I, A71V, V82I, I84V) in Complex with DRV
7maq
homo-2-mer501-599
1×017; 1×SO4;
Assess
HIV-1 Protease (I84V) in Complex with UMass10
7maa
homo-2-mer501-599
2×SO4; 1×A61;
Assess
X-ray crystal structure of wild type HIV-1 protease in complex with GRL-08513
6uwb
homo-2-mer501-599
1×QJY;
Assess
X-ray crystal structure of wild type HIV-1 protease in complex with GRL-08613
6uwc
homo-2-mer501-599
1×QK1;
Assess
Crystal structure of wild type HIV-1 protease in complex with darunavir
4hla
homo-2-mer501-599
1×017;
Assess
Drug Resistant HIV-1 Protease (L10I, V32I, L33F, K45I, M46I, I50V, A71V, V82I, I84V) in Complex wit…
7map
homo-2-mer501-599
1×017;
Assess
HIV-1 Protease (I84V) in Complex with UMass2
7ma3
homo-2-mer501-599
2×SO4; 1×K14;
Assess
HIV-1 PROTEASE TRIPLE MUTANT/TIPRANAVIR COMPLEX
1d4y
homo-2-mer501-599
1×TPV;
Assess
HIV-1 Protease (I84V) in Complex with UMass4
7ma5
homo-2-mer501-599
4×SO4; 1×K20;
Assess
HIV-1 Protease (I84V) in Complex with UMass3
7ma4
homo-2-mer501-599
1×SO4; 1×K2A;
Assess
HIV-1 Protease (I84V) in Complex with UMass5
7ma6
homo-2-mer501-599
4×SO4; 1×K19;
Assess
STRUCTURAL BASIS FOR SPECIFICITY OF RETROVIRAL PROTEASES
1a94
homo-2-mer501-599
1×0Q4;
Assess
Structure of HIV protease (Mutant Q7K L33I L63I V82F I84V ) complexed with KNI-577
1mrx
homo-2-mer501-599
1×K57;
Assess
HIV-1 PROTEASE COMPLEXED WITH THE INHIBITOR KNI-272
1hpx
homo-2-mer501-599
1×KNI;
Assess
HIV-1 Protease NL4-3 in complex with inhibitor, TL-3
2az8
homo-2-mer501-599
2×3TL;
Assess
Crystal Structure of HIV-1 Protease in Complex with an enamino-oxindole inhibitor
4fe6
homo-2-mer501-599
2×0TQ;
Assess
Crystal structure of the complex of resistant strain of hiv-1 protease(v82a mutant) with ritonavir
1rl8
homo-2-mer501-599
1×RIT;
Assess
Joint neutron and X-ray structure of per-deuterated HIV-1 protease in complex with clinical inhibit…
4jec
homo-2-mer501-599
1×CL; 1×478;
Assess
The HIV protease (mutant Q7K L33I L63I V82F I84V) complexed with KNI-764 (an inhibitor)
1msn
homo-2-mer501-599
1×JE2;
Assess
HIV-1 PROTEASE/U101935 COMPLEX
7upj
homo-2-mer501-599
1×INU;
Assess
The HIV protease (mutant Q7K L33I L63I) complexed with KNI-764 (an inhibitor)
1msm
homo-2-mer501-599
1×JE2;
Assess
CRYSTAL STRUCTURE AT 1.9 ANGSTROMS RESOLUTION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) II PROTEASE COM…
1hsg
homo-2-mer501-599
1×MK1;
Assess
Structure of HIV protease (Mutant Q7K L33I L63I) complexed with KNI-577
1mrw
homo-2-mer501-599
1×K57;
Assess
CRYSTALLOGRAPHIC ANALYSIS OF HUMAN IMMUNODEFICIENCY VIRUS 1 PROTEASE WITH AN ANALOG OF THE CONSERVE…
1a8k
homo-2-mer501-599
1×0Q4;
Assess
HIV-1 Protease NL4-3 6X mutant
2azc
homo-2-mer501-599
2×3TL;
Assess
HIV-1 Protease NL4-3 3X mutant in complex with inhibitor, TL-3
2azb
homo-2-mer501-599
2×3TL;
Assess
Structure of HIV PR resistant patient derived mutant (comprising 22 mutations) in complex with DRV
3t3c
homo-2-mer501-599
1×017; 2×BME; 2×SO4;
Assess
Crystal structure of HIV protease- metallacarborane complex
1ztz
homo-2-mer501-599
2×CB5;
Assess
Inhibitor of HIV protease with unusual binding mode potently inhibiting multi-resistant protease mu…
1izi
homo-2-mer501-599
2×CL; 1×Q50;
Assess
Crystal Structure of Multidrug Resistant HIV-1 Protease Clinical Isolate PR20 in Complex with p2-NC…
3uhl
homo-2-mer501-599
2×SO4;
Assess
Crystal structure of the complex of mutant HIV-1 protease (A71V, V82T, I84V) with an ethylenamine p…
1lzq
homo-2-mer501-599
1×0ZQ; 1×BME;
Assess
Crystal Structure of HIV-1 Protease (Q7K, L33I, L63I) in Complex with KNI-10074
3kdc
homo-2-mer501-599
1×JZP; 1×GOL; 4×CL;
Assess
HIV-1 PR mutant in complex with nelfinavir
2q63
homo-2-mer501-599
1×1UN;
Assess
Structure of HIV-1 protease mutant bound to indinavir
2b7z
homo-2-mer501-599
1×MK1;
Assess
HIV-1 PR mutant in complex with nelfinavir
2qak
homo-2-mer501-599
1×1UN;
Assess
Crystal structure of a HIV-1 Protease in complex with peptidomimetic inhibitor KI2-PHE-GLU-GLU-NH2
1u8g
homo-2-mer501-599
Assess
HIV-1 PROTEASE COMPLEX WITH U095438 [3-[1-(4-BROMOPHENYL) ISOBUTYL]-4-HYDROXYCOUMARIN
1upj
homo-2-mer501-599
2×U01;
Assess
Dimeric inhibitor of HIV-1 protease.
3t11
homo-2-mer501-599
2×3T1; 1×CL; 2×BME;
Assess
Structure of multiresistant HIV-1 protease in complex with darunavir
3ttp
homo-2-mer501-599
1×017; 2×CL; 1×BME;
Assess
HIV-1 Protease in complex with a chloro decorated pyrrolidine-based inhibitor
2qnq
homo-2-mer501-599
3×CL; 1×QN3;
Assess
HIV-1 protease in complex with an ethyleneamine inhibitor
1m0b
homo-2-mer501-599
1×0ZQ; 1×GOL;
Assess
HIV-1 PR mutant in complex with nelfinavir
2q64
homo-2-mer501-599
1×1UN;
Assess
Comparing the Accumulation of Active Site and Non-active Site Mutations in the HIV-1 Protease
1sh9
homo-2-mer501-599
1×RIT;
Assess
HIV-1 PROTEASE IN COMPLEX WITH SDZ283-910
1a8g
homo-2-mer501-599
1×2Z4;
Assess
HIV-1 PROTEASE TRIPLE MUTANT/U103265 COMPLEX
1hpo
homo-2-mer501-599
1×UNI;
Assess
HIV-1 PROTEASE V82F/I84V DOUBLE MUTANT/TIPRANAVIR COMPLEX
1d4s
homo-2-mer501-599
1×TPV;
Assess
HYDROXYETHYLENE ISOSTERE INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS-1 PROTEASE: STRUCTURE-ACTIVITY …
1aaq
homo-2-mer501-599
1×PSI;
Assess
HIV-1 Protease NL4-3 1X mutant
2az9
homo-2-mer501-599
2×3TL;
Assess
THE THREE-DIMENSIONAL STRUCTURE OF THE ASPARTYL PROTEASE FROM THE HIV-1 ISOLATE BRU
1hhp
homo-2-mer501-599
Assess
HIV-1 PROTEASE COMPLEX WITH U100313 ([3-[[3-[CYCLOPROPYL [4-HYDROXY-2OXO-6-[1-(PHENYLMETHYL)PROPYL]…
2upj
homo-2-mer501-599
1×U02;
Assess
CRYSTAL STRUCTURE OF THE COMPLEX OF HIV-1 PROTEASE WITH A PEPTIDOMIMETIC INHIBITOR
1fqx
homo-2-mer501-599
1×0ZT;
Assess
Structure of HIV-1 Protease in Complex with Potent Inhibitor KNI-272 Determined by Neutron Crystall…
2zye
homo-2-mer501-599
1×KNI;
Assess
Joint X-ray/neutron structure of HIV-1 protease triple mutant (V32I,I47V,V82I) with darunavir at pH…
5e5k
homo-2-mer501-599
1×017;
Assess

9 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
6rwm.1.Ahomo-12-mer0.751160-1431
8×ZN;75.35
Assess
6rwl.1.Bmonomer0.731160-1431
1×ZN;75.35
Assess
6rwl.1.Amonomer0.721160-1428
1×ZN;75.35
Assess
6v3k.3.Ahomo-4-mer0.721182-1436
95.11
Assess
7sep.1.Ahomo-2-mer0.71603-1152
98.56
Assess
5u1c.1.Ahomo-4-mer0.701182-1428
94.74
Assess
7t15.1.Ehomo-6-mer0.69133-352
84.42
Assess
1l6n.1.Amonomer0.682-283
96.11
Assess
7asl.1.Ahomo-18-mer0.64143-377
99.57
Assess